ARSI doublet therapy induced deeper and faster PSA responses compared with combined androgen blockade in men with mCSPC. Response rates to androgen receptor signaling inhibitors (ARSIs) in metastatic ...
At the age of 22 years old, Kecia Kesler established Account Recovery Specialist Inc. out of her father’s successful law firm to continue the family business after her father’s retirement. Having ...
Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort—Results from the Canary/EDRN Prostate Active Surveillance Study. Background: MDV3100, a ...
Account Recovery Specialists Inc. is a forward-looking company. Company leaders are continually seeking ways to improve processes, software and technology to stay on the cutting edge in an ...
The addition of androgen receptor signaling inhibitors (ARSIs) alongside standard androgen deprivation therapy (ADT) in advanced prostate cancer was associated with a significantly increased risk of ...
In this retrospective study, researchers sought to determine the efficacy, safety, and effectiveness of a reduced ARSI dose compared to a full dose in non-metastatic castration-resistant prostate ...
Activity of lutetium-177 PSMA (Lu-PSMA) and determinants of outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with cabazitaxel: The PACAP study. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results